policy, drug development

The FDA granted the drug, called Aduhelm, accelerated approval earlier this summer in a process that’s since drawn scrutiny.

A regulatory change initiated during the Obama administration appears set to be put into practice, allowing more than one supplier of cannabis research products.

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.

Race has been used to segment humanity and, by extension, establish and enforce a hierarchy in science. Individual and institutional commitments to racial justice in the sciences must involve political activity.

Rick Bright will no longer head the Biomedical Advanced Research and Development Authority and will instead work at the National Institutes of Health on diagnostics for SARS-CoV-2 infection.

Organizers have cancelled conferences, COVID-19 quarantines have prevented some scientists in China from visiting their labs, and travel restrictions have left researchers stranded.

In Chapter 14, author David Nutt describes the opioid crisis currently besetting the US.

Current bills in Congress would apply similar provisions to all federal agencies.

An inspector general finds that the agency was supposed to have received congressional approval before relocating facilities out of Washington, DC.

The answer has broad implications for paleontology research—and maybe for museum collections, too.

Some researchers say the abrupt end of the program will hobble the fight against a common parasite.

Most people who contracted the disease were unvaccinated and some state legislatures are now considering whether to curtail nonmedical vaccine exemptions.

A newly expanded genetic alphabet that includes four synthetic nucleotides highlights the need for strict boundaries on their use.

The Democrats’ takeover of the House inspires hope for science-based policies, but voters struck down several ballot initiatives to counteract climate change.

Becoming a neuroscientist with a service dog by your side presents numerous challenges. Joey Ramp, who went back to college to study her own post-traumatic stress disorder, is learning this the hard way.

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

Opponents of the proposal call the changes a “wildlife extinction package.”

United Airlines, British Airways, China Southern Airlines, and Qatar Airways face a formal complaint over their refusal to transport animals for scientific research.